
News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Comparing and Contrasting Barrier Isolator Decontamination Systems
A discussion of the validation and operation of two commercially available vapor-phase hydrogen peroxide decontamination systems is presented, based on a hands-on examination of both systems.
Advertisement
Articles in this issue
over 21 years ago
Still Waiting for Answersover 21 years ago
November 2004over 21 years ago
In the Spotlight-November 2004over 21 years ago
Searching for a Viable Business Modelover 21 years ago
FDA Moves To Implement New GMP PoliciesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
4
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
5




